-
VPC-14449
- names:
4-(4-(4,5-Dibromo-1H-imidazol-1-yl)thiazol-2-yl)morpholine
- CAS号:
1621375-32-3
MDL Number: - MF(分子式): C10H10Br2N4OS MW(分子量): 394.08
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | 4-(4-(4,5-Dibromo-1H-imidazol-1-yl)thiazol-2-yl)morpholine |
| 英文别名 | VPC-14449; VPC 14449; VPC14449; |
| CAS号 | 1621375-32-3 |
| Inchi | InChI=1S/C10H10Br2N4OS/c11-8-9(12)16(6-13-8)7-5-18-10(14-7)15-1-3-17-4-2-15/h5-6H,1-4H2 |
| InchiKey | KEFGZKYLWGZFFS-UHFFFAOYSA-N |
| 分子式 Formula | C10H10Br2N4OS |
| 分子量 Molecular Weight | 394.08 |
| 溶解度Solubility | |
| 性状 | Solid powder |
| 储藏条件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 产品说明 | VPC-14449(CAS:1621375-32-3):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。 |
| Introduction | VPC-14449 is a specific inhibitor of AR-DBD. It acts by inhibiting both Y594A and Q592A mutants, blocking the interaction of the AR with androgen response elements in the nucleus.. |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Dalal K, Roshan-Moniri M, Sharma A, Li H, Ban F, Hassona MD, Hsing M, Singh K, LeBlanc E, Dehm S, Tomlinson Guns ES, Cherkasov A, Rennie PS. Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer. J Biol Chem. 2014 Sep 19;289(38):26417-29. doi: 10.1074/jbc.M114.553818. Epub 2014 Aug [1]Erratum in: J Biol Chem. 2015 Oct 23;290(43):25850. J Biol Chem. 2014 Dec 5;289(49):33877. Hessein, Mohamed [Corrected to Hassona, Mohamed D]. J Biol Chem. 2017 Mar 10;292(10 ):4359. PubMed PMID: 25086042; PubMed Central PMCID: PMC4176249. |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


